<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34648081</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1535-1645</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Current psychiatry reports</Title><ISOAbbreviation>Curr Psychiatry Rep</ISOAbbreviation></Journal><ArticleTitle>Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19.</ArticleTitle><Pagination><StartPage>68</StartPage><MedlinePgn>68</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">68</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11920-021-01275-3</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">We present biological and psychological factors implicated in psychiatric manifestations of SARS-CoV-2, as well as its neuroinvasive capability and immune pathophysiology.</AbstractText><AbstractText Label="RECENT FINDINGS">Preexisting mental illness leads to worse clinical outcomes in COVID-19. The presence of the virus was reported in the cerebrospinal fluid (CSF) and brain tissue post-mortem. Most common psychiatric manifestations include delirium, mood disorders, anxiety disorders, and posttraumatic stress disorder. "Long-COVID" non-syndromal presentations include "brain-fogginess," autonomic instability, fatigue, and insomnia. SARS-CoV-2 infection can trigger prior vulnerabilities based on the priming of microglia and other cells, induced or perpetuated by aging and mental and physical illnesses. COVID-19 could further induce priming of neuroimmunological substrates leading to exacerbated immune response and autoimmunity targeting structures in the central nervous system (CNS), in response to minor immune activating environmental exposures, including stress, minor infections, allergens, pollutants, and traumatic brain injury.</AbstractText><CopyrightInformation>&#xa9; 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tizenberg</LastName><ForeName>Boris N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Mood and Anxiety Program, Department of Psychiatry, University of Maryland School of Medicine, 685 W. Baltimore Street, Suite# 930, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brenner</LastName><ForeName>Lisa A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>VA Rocky Mountain Mental Illness Research Education and Clinical Center (MIRECC), Rocky Mountain Regional Veterans Affairs (VA) Medical Center (RMRVAMC), Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Military and Veteran Microbiome: Consortium for Research and Education, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowry</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>VA Rocky Mountain Mental Illness Research Education and Clinical Center (MIRECC), Rocky Mountain Regional Veterans Affairs (VA) Medical Center (RMRVAMC), Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Military and Veteran Microbiome: Consortium for Research and Education, Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroscience, University of Colorado Boulder, Boulder, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroscience, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okusaga</LastName><ForeName>Olaoluwa O</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael E DeBakey VA Medical Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benavides</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoisington</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>VA Rocky Mountain Mental Illness Research Education and Clinical Center (MIRECC), Rocky Mountain Regional Veterans Affairs (VA) Medical Center (RMRVAMC), Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Military and Veteran Microbiome: Consortium for Research and Education, Aurora, CO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Engineering and Management, Air Force Institute of Technology, Wright-Patterson Air Force Base, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benros</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Biological and Precision Psychiatry, Copenhagen Research Centre for Mental Health, Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stiller</LastName><ForeName>John W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Mood and Anxiety Program, Department of Psychiatry, University of Maryland School of Medicine, 685 W. Baltimore Street, Suite# 930, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saint Elizabeths Hospital-DBH Psychiatry Residency Training Program, Washington, DC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maryland State Athletic Commission, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessler</LastName><ForeName>Ronald C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Health Care Policy Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Postolache</LastName><ForeName>Teodor T</ForeName><Initials>TT</Initials><Identifier Source="ORCID">0000-0001-6056-4244</Identifier><AffiliationInfo><Affiliation>Mood and Anxiety Program, Department of Psychiatry, University of Maryland School of Medicine, 685 W. Baltimore Street, Suite# 930, Baltimore, MD, USA. tpostola@som.umaryland.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Rocky Mountain Mental Illness Research Education and Clinical Center (MIRECC), Rocky Mountain Regional Veterans Affairs (VA) Medical Center (RMRVAMC), Aurora, CO, USA. tpostola@som.umaryland.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Military and Veteran Microbiome: Consortium for Research and Education, Aurora, CO, USA. tpostola@som.umaryland.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Integrated Service Network (VISN) 5, VA Capitol Health Care Network, Baltimore, MD, USA. tpostola@som.umaryland.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Psychiatry Rep</MedlineTA><NlmUniqueID>100888960</NlmUniqueID><ISSNLinking>1523-3812</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013313" MajorTopicYN="Y">Stress Disorders, Post-Traumatic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Neuroinvasion</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric</Keyword><Keyword MajorTopicYN="N">Priming</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Dr. Christopher A. Lowry serves on the Scientific Advisory Board of Immodulon Therapeutics, Ltd., is Co-founder and Chief Scientific Officer of Mycobacteria Therapeutics Corporation, serves as an unpaid scientific consultant to Aurum Switzerland AG, and is a member of the faculty of the Integrative Psychiatry Institute. In the past 3&#xa0;years, Dr. Kessler was a consultant for Datastat, Inc., Holmusk, RallyPoint Networks, Inc., and&#xa0;Sage&#xa0;Therapeutics. Dr. Kessler also has&#xa0;stock options in Mirah, PYM, and Roga Sciences. All other authors did not declare any conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34648081</ArticleId><ArticleId IdType="pmc">PMC8485771</ArticleId><ArticleId IdType="doi">10.1007/s11920-021-01275-3</ArticleId><ArticleId IdType="pii">10.1007/s11920-021-01275-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jansen JM, Gerlach T, Elbahesh H, Rimmelzwaan GF, Saletti G. Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. J Clin Virol. 2019;119:44&#x2013;52. doi: 10.1016/j.jcv.2019.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2019.08.009</ArticleId><ArticleId IdType="pubmed">31491709</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) Front Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17(1):231. 10.1186/s12974-020-01896-0.&#xa0;Details how the monocytes and macrophages are manipulated to serve the aims of transportation of the virus and its panorgan invasion.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MD. Macrophages: a Trojan horse in COVID-19? Nat Rev Immunol. 2020;20(6):351. doi: 10.1038/s41577-020-0317-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0317-2</ArticleId><ArticleId IdType="pmc">PMC7186930</ArticleId><ArticleId IdType="pubmed">32303696</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Sharif K, O&#x2019;Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi: 10.1016/j.autrev.2020.102537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102537</ArticleId><ArticleId IdType="pmc">PMC7195002</ArticleId><ArticleId IdType="pubmed">32251717</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Guo R, Lei L, Liu H, Wang Y, Wang Y, et al. COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J Leukoc Biol. 2020 doi: 10.1002/jlb.4hi0720-470r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.4hi0720-470r</ArticleId><ArticleId IdType="pmc">PMC7675546</ArticleId><ArticleId IdType="pubmed">33040384</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327&#x2013;31. doi: 10.23812/conti-e.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/conti-e</ArticleId><ArticleId IdType="pubmed">32171193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich H, Pillat MM. CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep. 2020;16(3):434&#x2013;40. doi: 10.1007/s12015-020-09976-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-09976-7</ArticleId><ArticleId IdType="pmc">PMC7167302</ArticleId><ArticleId IdType="pubmed">32307653</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunn BM, Alter G. Modulating antibody functionality in infectious disease and vaccination. Trends Mol Med. 2016;22(11):969&#x2013;82. doi: 10.1016/j.molmed.2016.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.09.002</ArticleId><ArticleId IdType="pmc">PMC8767654</ArticleId><ArticleId IdType="pubmed">27756530</ArticleId></ArticleIdList></Reference><Reference><Citation>Murin CD, Wilson IA, Ward AB. Antibody responses to viral infections: a structural perspective across three different enveloped viruses. Nat Microbiol. 2019;4(5):734&#x2013;47. doi: 10.1038/s41564-019-0392-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0392-y</ArticleId><ArticleId IdType="pmc">PMC6818971</ArticleId><ArticleId IdType="pubmed">30886356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027&#x2013;34. doi: 10.1093/cid/ciaa344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa344</ArticleId><ArticleId IdType="pmc">PMC7184337</ArticleId><ArticleId IdType="pubmed">32221519</ArticleId></ArticleIdList></Reference><Reference><Citation>Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845&#x2013;8. doi: 10.1038/s41591-020-0897-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0897-1</ArticleId><ArticleId IdType="pubmed">32350462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou B, Li T-D, Zheng S-F, Su Y-Y, Li Z-Y, Liu W, et al. Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset. Eur Respir J. 2020;56(2):2000763. doi: 10.1183/13993003.00763-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00763-2020</ArticleId><ArticleId IdType="pmc">PMC7401320</ArticleId><ArticleId IdType="pubmed">32430429</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Bartley CM, Chow RD, Ngo TT, Jiang R, Zamecnik CR, et al. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med. 2021 doi: 10.1016/j.xcrm.2021.100288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100288</ArticleId><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L-Q, Huang T, Wang Y-Q, Wang Z-P, Liang Y, Huang T-B, et al. COVID-19 patients&#x2019; clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577&#x2013;83. doi: 10.1002/jmv.25757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25757</ArticleId><ArticleId IdType="pmc">PMC7228329</ArticleId><ArticleId IdType="pubmed">32162702</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Sole F, Farcomeni A, Loffredo L, Carnevale R, Menichelli D, Vicario T, et al. Features of severe COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10):e13378. doi: 10.1111/eci.13378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13378</ArticleId><ArticleId IdType="pmc">PMC7435565</ArticleId><ArticleId IdType="pubmed">32860457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragholm K, Andersen MP, Gerds TA, Butt JH, &#xd8;stergaard L, Polcwiartek C, et al. Association between male sex and outcomes of coronavirus disease (Covid-19) - a Danish nationwide, register-based study. Clin Infect Dis. 2019 doi: 10.1093/cid/ciaa924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa924</ArticleId><ArticleId IdType="pmc">PMC7454435</ArticleId><ArticleId IdType="pubmed">32634827</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442&#x2013;7. doi: 10.1038/s41577-020-0348-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0348-8</ArticleId><ArticleId IdType="pmc">PMC7288618</ArticleId><ArticleId IdType="pubmed">32528136</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626&#x2013;38. doi: 10.1038/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837):315&#x2013;20. doi: 10.1038/s41586-020-2700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Pekosz A, Park H-S, Ursin RL, Shapiro JR, Benner SE, et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Investig. 2020;130(11):6141&#x2013;50. doi: 10.1172/JCI142004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI142004</ArticleId><ArticleId IdType="pmc">PMC7598041</ArticleId><ArticleId IdType="pubmed">32764200</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dube M, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019. 10.3390/v12010014.&#xa0;Important conceptual article about neuroinvasive capability of coronaviruses and other respiratory viruses, published simultanously with the onset of the pandemic.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7020001</ArticleId><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli LH, Postolache TT. Airborne inflammatory factors: &#x201c;from the nose to the brain&#x201d;. Front Biosci (Schol Ed) 2010;2:135&#x2013;52. doi: 10.2741/s52.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/s52</ArticleId><ArticleId IdType="pubmed">20036935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori I, Nishiyama Y, Yokochi T, Kimura Y. Olfactory transmission of neurotropic viruses. J Neurovirol. 2005;11(2):129&#x2013;37. doi: 10.1080/13550280590922793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280590922793</ArticleId><ArticleId IdType="pubmed">16036791</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedras-Vasconcelos JA, Goucher D, Puig M, Tonelli LH, Wang V, Ito S, et al. CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus. J Immunol. 2006;176(8):4940&#x2013;9. doi: 10.4049/jimmunol.176.8.4940.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.8.4940</ArticleId><ArticleId IdType="pubmed">16585590</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar V, Kao M, Hamir AN, Sheng H, Koprowski H, Dietzschold B. Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J Virol. 1992;66(2):992&#x2013;8. doi: 10.1128/JVI.66.2.992-998.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.66.2.992-998.1992</ArticleId><ArticleId IdType="pmc">PMC240801</ArticleId><ArticleId IdType="pubmed">1731117</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori I, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, et al. The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus. Virology. 2005;334(1):51&#x2013;58. doi: 10.1016/j.virol.2005.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.01.023</ArticleId><ArticleId IdType="pubmed">15749122</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki T, Itamura S, Nishimura H, Sato Y, Tashiro M, Hashikawa T, et al. Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation. Acta Neuropathol. 2004;108(6):485&#x2013;92. doi: 10.1007/s00401-004-0909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0909-0</ArticleId><ArticleId IdType="pubmed">15480712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauder CJ, Vandenburgh KM, Iskow RC, Malik T, Carbone KM, Rubin SA. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology. 2006;350(1):48&#x2013;57. doi: 10.1016/j.virol.2006.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.01.035</ArticleId><ArticleId IdType="pubmed">16494912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellin CI, Davoust N, Guillaume V, Baas D, Belin MF, Buckland R, et al. High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. J Virol. 2006;80(13):6420&#x2013;9. doi: 10.1128/jvi.00209-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00209-06</ArticleId><ArticleId IdType="pmc">PMC1488937</ArticleId><ArticleId IdType="pubmed">16775330</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2020 doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020. 10.1126/science.abd2985.&#xa0;Important article demonstrating an alternative pathway particularly relevant to the olfactory entry and systemic as well.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Dube M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018 doi: 10.1128/JVI.00404-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00404-18</ArticleId><ArticleId IdType="pmc">PMC6096804</ArticleId><ArticleId IdType="pubmed">29925652</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacomy H, St-Jean JR, Brison E, Marceau G, Desforges M, Talbot PJ. Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease in BALB/c mice from encephalitis to flaccid paralysis and demyelination. J Neurovirol. 2010;16(4):279&#x2013;93. doi: 10.3109/13550284.2010.497806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13550284.2010.497806</ArticleId><ArticleId IdType="pmc">PMC7095228</ArticleId><ArticleId IdType="pubmed">20642316</ArticleId></ArticleIdList></Reference><Reference><Citation>Brison E, Jacomy H, Desforges M, Talbot PJ. Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein. J Virol. 2011;85(23):12464&#x2013;73. doi: 10.1128/JVI.05576-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05576-11</ArticleId><ArticleId IdType="pmc">PMC3209392</ArticleId><ArticleId IdType="pubmed">21957311</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264&#x2013;75. doi: 10.1128/jvi.00737-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00737-08</ArticleId><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. The S1 protein of SARS-CoV-2 crosses the blood&#x2013;brain barrier in mice. Nat Neurosci. 2020 doi: 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JM, Tan BH, Wu S, Gui Y, Suo JL, Li YC. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection. J Med Virol. 2020 doi: 10.1002/jmv.26570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26570</ArticleId><ArticleId IdType="pmc">PMC7537172</ArticleId><ArticleId IdType="pubmed">33002209</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55&#x2013;8. doi: 10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Zhang M, Wang J, Gao J. Sars-Cov-2: Underestimated damage to nervous system. Travel Med Infect Dis. 2020 doi: 10.1016/j.tmaid.2020.101642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101642</ArticleId><ArticleId IdType="pmc">PMC7269702</ArticleId><ArticleId IdType="pubmed">32220634</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues RB, Mendes-Correa MC, de Moura Leite FBV, Sabino EC, Salarini DZ, Claro I, et al. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease. J Neurol. 2020;267(11):3154&#x2013;6. doi: 10.1007/s00415-020-09996-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09996-w</ArticleId><ArticleId IdType="pmc">PMC7305694</ArticleId><ArticleId IdType="pubmed">32564153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadakar N, Ghaemmaghami S, Masoompour SM, Shirazi Yeganeh B, Akbari A, Hooshmandi S, et al. A first case of acute cerebellitis associated with coronavirus disease (COVID-19): a case report and literature review. The Cerebellum. 2020;19(6):911&#x2013;4. doi: 10.1007/s12311-020-01177-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-020-01177-9</ArticleId><ArticleId IdType="pmc">PMC7393247</ArticleId><ArticleId IdType="pubmed">32737799</ArticleId></ArticleIdList></Reference><Reference><Citation>Westhoff TH, Seibert FS, Bauer F, Stervbo U, Anft M, Doevelaar AAN, et al. Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient. Am J Transplant. 2020;20(11):3216&#x2013;20. doi: 10.1111/ajt.16223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16223</ArticleId><ArticleId IdType="pmc">PMC9800697</ArticleId><ArticleId IdType="pubmed">32713123</ArticleId></ArticleIdList></Reference><Reference><Citation>Virhammar J, Kumlien E, F&#xe4;llmar D, Frithiof R, Jackmann S, Sk&#xf6;ld MK, et al. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology. 2020;95(10):445&#x2013;9. doi: 10.1212/wnl.0000000000010250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000010250</ArticleId><ArticleId IdType="pmc">PMC7538220</ArticleId><ArticleId IdType="pubmed">32586897</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodamoradi Z, Hosseini SA, Gholampoor Saadi MH, Mehrabi Z, Sasani MR, Yaghoubi S. COVID-19 meningitis without pulmonary involvement with positive cerebrospinal fluid PCR. Eur J Neurol. 2020;27(12):2668&#x2013;9. doi: 10.1111/ene.14536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14536</ArticleId><ArticleId IdType="pubmed">32926584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardani M, Nadji SA, Sarhangipor KA, Sharifi-Razavi A, Baziboroun M. COVID-19 infection recurrence presenting with meningoencephalitis. New Microbes New Infect. 2020;37:100732. doi: 10.1016/j.nmni.2020.100732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100732</ArticleId><ArticleId IdType="pmc">PMC7376341</ArticleId><ArticleId IdType="pubmed">32789020</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatr. 2020;91(8):846&#x2013;8. doi: 10.1136/jnnp-2020-323522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323522</ArticleId><ArticleId IdType="pubmed">32354770</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann B, Schmidbauer ML, Dimitriadis K, Otto S, Knier B, Niesen W-D, et al. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms. J Neurol Sci. 2020;418:117090. doi: 10.1016/j.jns.2020.117090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117090</ArticleId><ArticleId IdType="pmc">PMC7417278</ArticleId><ArticleId IdType="pubmed">32805440</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590&#x2013;2. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S, Lersy F, S&#xe8;ze Jd, Ferr&#xe9; J-C, Maamar A, Carsin-Nicol B, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297(2):E242&#x2013;E51. doi: 10.1148/radiol.2020202222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202222</ArticleId><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Skok K, Stelzl E, Trauner M, Kessler HH, Lax SF. Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage. Virchows Arch. 2020 doi: 10.1007/s00428-020-02903-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-020-02903-8</ArticleId><ArticleId IdType="pmc">PMC7438212</ArticleId><ArticleId IdType="pubmed">32815036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantonen J, Mahzabin S, M&#xe4;yr&#xe4;np&#xe4;&#xe4; MI, Tynninen O, Paetau A, Andersson N, et al. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30(6):1012&#x2013;6. doi: 10.1111/bpa.12889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12889</ArticleId><ArticleId IdType="pmc">PMC7436498</ArticleId><ArticleId IdType="pubmed">32762083</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MP, Le Quesne J, Officer-Jones L, Teod&#xf2;sio A, Thaventhiran J, Ficken C, et al. Neuropathological findings in two patients with fatal COVID-19. Neuropathol Appl Neurobiol. 2021;5:87. doi: 10.1111/nan.12662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12662</ArticleId><ArticleId IdType="pubmed">32895961</ArticleId></ArticleIdList></Reference><Reference><Citation>Remmelink M, De Mendon&#xe7;a R, D&#x2019;Haene N, De Clercq S, Verocq C, Lebrun L, et al. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit Care. 2020;24(1):495. doi: 10.1186/s13054-020-03218-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03218-5</ArticleId><ArticleId IdType="pmc">PMC7422463</ArticleId><ArticleId IdType="pubmed">32787909</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Mothes R, Franz J, Laue M, et al. Olfactory transmucosal SARS-CoV-2 invasion as port of central nervous system entry in individuals with COVID-19. Nat Neurosci.2021;24, 168&#x2013;175. 10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J Med Virol. 2020;92(7):699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dalahmah O, Thakur KT, Nordvig AS, Prust ML, Roth W, Lignelli A, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun. 2020;8(1):147. doi: 10.1186/s40478-020-01024-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01024-2</ArticleId><ArticleId IdType="pmc">PMC7447601</ArticleId><ArticleId IdType="pubmed">32847628</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, et al. Neuropathological features of Covid-19. N Engl J Med. 2020;383(10):989&#x2013;92. doi: 10.1056/NEJMc2019373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Freij BJ, Gebara BM, Tariq R, Wang A-M, Gibson J, El-Wiher N, et al. Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child. BMC Pediatr. 2020;20(1):429. doi: 10.1186/s12887-020-02308-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-020-02308-1</ArticleId><ArticleId IdType="pmc">PMC7479402</ArticleId><ArticleId IdType="pubmed">32907595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. The Lancet Microbe. 2020;1(6):e245&#x2013;e253. doi: 10.1016/S2666-5247(20)30115-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30115-4</ArticleId><ArticleId IdType="pmc">PMC7440861</ArticleId><ArticleId IdType="pubmed">32844161</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulfamante G, Chiumello D, Canevini MP, Priori A, Mazzanti M, Centanni S, et al. First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem. Minerva Anestesiol. 2020;86(6):678&#x2013;9. doi: 10.23736/s0375-9393.20.14772-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/s0375-9393.20.14772-2</ArticleId><ArticleId IdType="pubmed">32401000</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218 (3): e20202135. 10.1101/2020.06.25.169946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S, Wei N, Jiang J, Wu L, Sheng J, Zhou J, et al. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder. J Affect Disord. 2020;277:337&#x2013;40. doi: 10.1016/j.jad.2020.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.08.031</ArticleId><ArticleId IdType="pmc">PMC7439825</ArticleId><ArticleId IdType="pubmed">32858315</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C-W, Syue L-S, Tsai Y-S, Li M-C, Lo C-L, Tsai C-S, et al. Anosmia and olfactory tract neuropathy in a case of COVID-19. J Microbiol, Immunol Infect. 2020 doi: 10.1016/j.jmii.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7305498</ArticleId><ArticleId IdType="pubmed">32576457</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin E, Lantos JE, Strauss SB, Phillips CD, Campion TR, Navi BB, et al. Brain imaging of patients with COVID-19: findings at an academic institution during the height of the outbreak in New York City. Am J Neuroradiol. 2020;41(11):2001&#x2013;2008. doi: 10.3174/ajnr.A6793.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6793</ArticleId><ArticleId IdType="pmc">PMC7658823</ArticleId><ArticleId IdType="pubmed">32819899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Roy Wong L-Y, Li K, Verma AK, Ortiz M, Wohlford-Lenane C, et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589, 603&#x2013;607. 10.1038/s41586-020-2943-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2943-z</ArticleId><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagre A, Lewis J, Eckley M, Zhan S, Rocha SM, Sexton NR, et al. SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: implications for reverse zoonosis to New World rodents. bioRxiv. 2020:2020.&#xa0;10.1101/2020.08.07.241810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168874</ArticleId><ArticleId IdType="pubmed">34010360</ArticleId></ArticleIdList></Reference><Reference><Citation>Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikkema L, et al. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. bioRxiv. 2020:2020.04.19.049254. 10.1101/2020.04.19.049254.</Citation></Reference><Reference><Citation>Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369(6499):50&#x2013;54. doi: 10.1126/science.abc1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, et al. Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. MedRxiv. 2020. 10.1101/2020.05.18.20099960.</Citation></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6(31):5801. doi: 10.1126/sciadv.abc5801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesel-Lemoine M, Millet J, Vidalain PO, Law H, Vabret A, Lorin V, et al. A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes. J Virol. 2012;86(14):7577&#x2013;87. doi: 10.1128/JVI.00269-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00269-12</ArticleId><ArticleId IdType="pmc">PMC3416289</ArticleId><ArticleId IdType="pubmed">22553325</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X, Hu W, Yu H, Zhao L, Zhao Y, Zhao Y. High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients. bioRxiv. 2020:2020.07.18.210120.&#xa0;10.1101/2020.07.18.210120.</Citation></Reference><Reference><Citation>Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415&#x2013;24. doi: 10.1084/jem.20050828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050828</ArticleId><ArticleId IdType="pmc">PMC2213088</ArticleId><ArticleId IdType="pubmed">16043521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls JM, Butany J, Poon LL, Chan KH, Beh SL, Poutanen S, et al. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med. 2006;3(2):e27. doi: 10.1371/journal.pmed.0030027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0030027</ArticleId><ArticleId IdType="pmc">PMC1324951</ArticleId><ArticleId IdType="pubmed">16379499</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins AR. Human macrophages are susceptible to coronavirus OC43. Adv Exp Med Biol. 1998;440:635&#x2013;9. doi: 10.1007/978-1-4615-5331-1_82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4615-5331-1_82</ArticleId><ArticleId IdType="pubmed">9782339</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M, Miletti TC, Gagnon M, Talbot PJ. Activation of human monocytes after infection by human coronavirus 229E. Virus Res. 2007;130(1&#x2013;2):228&#x2013;40. doi: 10.1016/j.virusres.2007.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2007.06.016</ArticleId><ArticleId IdType="pmc">PMC7114174</ArticleId><ArticleId IdType="pubmed">17669539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wentworth DE, Tresnan DB, Turner BC, Lerman IR, Bullis B, Hemmila EM, et al. Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo. Virology. 2005;335(2):185&#x2013;97. doi: 10.1016/j.virol.2005.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.02.023</ArticleId><ArticleId IdType="pmc">PMC7111747</ArticleId><ArticleId IdType="pubmed">15840518</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumaza A, Gay L, Mezouar S, Diallo AB, Michel M, Desnues B, et al. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis. J Infect Dis. 2021;224(3):395-406. 10.1093/infdis/jiab044. PMID: 33493287; PMCID: PMC7928817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab044</ArticleId><ArticleId IdType="pmc">PMC7928817</ArticleId><ArticleId IdType="pubmed">33493287</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(19):8913&#x2013;21. doi: 10.1128/jvi.74.19.8913-8921.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.19.8913-8921.2000</ArticleId><ArticleId IdType="pmc">PMC102086</ArticleId><ArticleId IdType="pubmed">10982334</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N, C&#xf4;t&#xe9; G, Lachance C, Tardieu M, Cashman NR, Talbot PJ. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol. 1999;73(4):3338&#x2013;50. doi: 10.1128/JVI.73.4.3338-3350.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.4.3338-3350.1999</ArticleId><ArticleId IdType="pmc">PMC104098</ArticleId><ArticleId IdType="pubmed">10074188</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N, Ekand&#xe9; S, C&#xf4;t&#xe9; G, Lachance C, Chagnon F, Tardieu M, et al. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol. 1999;73(4):3326&#x2013;37. doi: 10.1128/JVI.73.4.3326-3337.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.4.3326-3337.1999</ArticleId><ArticleId IdType="pmc">PMC104097</ArticleId><ArticleId IdType="pubmed">10074187</ArticleId></ArticleIdList></Reference><Reference><Citation>Osipova ED, Semyachkina-Glushkovskaya OV, Morgun AV, Pisareva NV, Malinovskaya NA, Boitsova EB, et al. Gliotransmitters and cytokines in the control of blood-brain barrier permeability. Rev Neurosci. 2018;29(5):567&#x2013;91. doi: 10.1515/revneuro-2017-0092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2017-0092</ArticleId><ArticleId IdType="pubmed">29306934</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Feng Z, Diao B, Wang R, Wang G, Wang C et al. The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly decimates human spleens and lymph nodes. medRxiv. 2020:2020.03.27.20045427. 10.1101/2020.03.27.20045427.</Citation></Reference><Reference><Citation>Cui C, Xu P, Li G, Qiao Y, Han W, Geng C, et al. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system. Redox Biol. 2019;26:101295. doi: 10.1016/j.redox.2019.101295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101295</ArticleId><ArticleId IdType="pmc">PMC6831892</ArticleId><ArticleId IdType="pubmed">31421410</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742. doi: 10.1016/j.antiviral.2020.104742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104742</ArticleId><ArticleId IdType="pmc">PMC7114094</ArticleId><ArticleId IdType="pubmed">32057769</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Zhao Y, Xu G, Zhang K, Jia W, Sun Y, et al. The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of neurotropism. Viruses. 2019 doi: 10.3390/v11100972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11100972</ArticleId><ArticleId IdType="pmc">PMC6832359</ArticleId><ArticleId IdType="pubmed">31652591</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatr. 2020 doi: 10.1016/S2215-0366(20)30203-0..</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0.</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Okusaga O, Yolken RH, Langenberg P, Lapidus M, Arling TA, Dickerson FB, et al. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J Affect Disord. 2011;130(1&#x2013;2):220&#x2013;225. doi: 10.1016/j.jad.2010.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2010.09.029</ArticleId><ArticleId IdType="pmc">PMC3043161</ArticleId><ArticleId IdType="pubmed">21030090</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1&#x2013;11. doi: 10.1002/ana.25807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25807</ArticleId><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatr. 2020 doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez CM, D&#xed;az-Maroto I, Fern&#xe1;ndez-D&#xed;az E, S&#xe1;nchez-Larsen &#xc1;, Layos-Romero A, Garc&#xed;a-Garc&#xed;a J, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060&#x2013;e1070. doi: 10.1212/wnl.0000000000009937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000009937</ArticleId><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease in Wuhan China. JAMA Neurol. 2019 doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251&#x2013;61. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268&#x2013;70. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19&#x2013;associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296(2):E119&#x2013;E120. doi: 10.1148/radiol.2020201187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201187</ArticleId><ArticleId IdType="pmc">PMC7233386</ArticleId><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarma D, Bilello LA. A case report of acute transverse myelitis following novel coronavirus infection. Clin Pract Cases Emerg Med. 2020;4(3):321&#x2013;23. doi: 10.5811/cpcem.2020.5.47937.</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/cpcem.2020.5.47937</ArticleId><ArticleId IdType="pmc">PMC7434287</ArticleId><ArticleId IdType="pubmed">32926676</ArticleId></ArticleIdList></Reference><Reference><Citation>Valiuddin H, Skwirsk B, Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: a case-report. Brain Behav Immun Health. 2020;5:100091. doi: 10.1016/j.bbih.2020.100091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100091</ArticleId><ArticleId IdType="pmc">PMC7275168</ArticleId><ArticleId IdType="pubmed">32835294</ArticleId></ArticleIdList></Reference><Reference><Citation>AlKetbi R, AlNuaimi D, AlMulla M, AlTalai N, Samir M, Kumar N, et al. Acute myelitis as a neurological complication of Covid-19: a case report and MRI findings. Radiol Case Rep. 2020;15(9):1591&#x2013;5. doi: 10.1016/j.radcr.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radcr.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7275163</ArticleId><ArticleId IdType="pubmed">32685076</ArticleId></ArticleIdList></Reference><Reference><Citation>Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R, Kr&#xe4;mer S, et al. Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020;267(8):2196&#x2013;7. doi: 10.1007/s00415-020-09934-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09934-w</ArticleId><ArticleId IdType="pmc">PMC7250275</ArticleId><ArticleId IdType="pubmed">32458198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohal S, Mossammat M. COVID-19 presenting with seizures. IDCases. 2020;20:e00782. doi: 10.1016/j.idcr.2020.e00782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2020.e00782</ArticleId><ArticleId IdType="pmc">PMC7194035</ArticleId><ArticleId IdType="pubmed">32363146</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogra S, Jain R, Cao M, Bilaloglu S, Zagzag D, Hochman S, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis. 2020;29(8):104984. doi: 10.1016/j.jstrokecerebrovasdis.2020.104984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.104984</ArticleId><ArticleId IdType="pmc">PMC7245254</ArticleId><ArticleId IdType="pubmed">32689588</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020 doi: 10.1136/svn-2020-000431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000431</ArticleId><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020;50(3):587&#x2013;95. doi: 10.1007/s11239-020-02228-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02228-y</ArticleId><ArticleId IdType="pmc">PMC7358286</ArticleId><ArticleId IdType="pubmed">32661757</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60. doi: 10.1056/NEJMc2009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer MC, Ascione T, Pagliano P. Neurologic aspects of covid-19: a concise review. Infez Med. 2020;28(suppl 1):42&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32532937</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116&#x2013;20. doi: 10.1515/cclm-2020-0188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0188</ArticleId><ArticleId IdType="pubmed">32172226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844&#x2013;7. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. doi: 10.1056/NEJMc2007575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;8. doi: 10.1016/s0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Guervilly C, Burtey S, Sabatier F, Cauchois R, Lano G, Abdili E, et al. Circulating endothelial cells as a marker of endothelial injury in severe COVID-19. J Infect Dis. 2020 doi: 10.1093/infdis/jiaa528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa528</ArticleId><ArticleId IdType="pmc">PMC7454721</ArticleId><ArticleId IdType="pubmed">32812049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaseda ET, Levine AJ. Post-traumatic stress disorder: a differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol. 2020;34(7&#x2013;8):1498&#x2013;1514. doi: 10.1080/13854046.2020.1811894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2020.1811894</ArticleId><ArticleId IdType="pubmed">32847484</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Gao Q, Yang L, Yang Y, Xia W, Cai X, et al. Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of coronavirus disease-2019 (Covid-19) from China. PLoS ONE. 2020;15(12):e0243883. doi: 10.1371/journal.pone.0243883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243883</ArticleId><ArticleId IdType="pmc">PMC7746260</ArticleId><ArticleId IdType="pubmed">33332386</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X, Hu X, Ekumi IO, Wang J, An Y, Li Z, et al. Psychological distress and its correlates among COVID-19 survivors during early convalescence across age groups. Am J Geriatr Psychiatr. 2020;28(10):1030&#x2013;1039. doi: 10.1016/j.jagp.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7347493</ArticleId><ArticleId IdType="pubmed">32753338</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594-600. 10.1016/j.bbi.2020.07.037. An investigation on psychiatric syndromes and their predictors 1 month after hospitalization for COVID-19 in Milan, Italy.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The lancet Psychiatry. 2020;7(10):875&#x2013;82. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CM, Komisar JR, Mourad A, Kincaid BR. COVID-19-associated brief psychotic disorder. BMJ Case Rep. 2020;13(8):e236940. doi: 10.1136/bcr-2020-236940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-236940</ArticleId><ArticleId IdType="pmc">PMC7418683</ArticleId><ArticleId IdType="pubmed">32784244</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim ST, Janaway B, Costello H, Trip A, Price G. Persistent psychotic symptoms following COVID-19 infection. BJPsych Open. 2020;6(5):e105. doi: 10.1192/bjo.2020.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2020.76</ArticleId><ArticleId IdType="pmc">PMC7477483</ArticleId><ArticleId IdType="pubmed">32696735</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando SJ, Klepacz L, Lynch S, Tavakkoli M, Dornbush R, Baharani R, et al. COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020;61(5):551&#x2013;555. doi: 10.1016/j.psym.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psym.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7236749</ArticleId><ArticleId IdType="pubmed">32593479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M, Kim S, Lindsell C, Rose E, Shapiro N, Files D, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, March&#x2013;June 2020. MMWR Morbidity and Mortality Weekly Report. 2020;69. 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y-M, Shang Y-M, Song W-B, Li Q-Q, Xie H, Xu Q-F, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020 doi: 10.1016/j.eclinm.2020.100463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.028</ArticleId><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Group ftGAC-P-ACS. persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;5. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;5. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020;10(7):806&#x2013;13. doi: 10.1002/alr.22579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22579</ArticleId><ArticleId IdType="pmc">PMC7262089</ArticleId><ArticleId IdType="pubmed">32279441</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonfils P, Avan P, Faulcon P, Malinvaud D. Distorted odorant perception: analysis of a series of 56 patients with parosmia. Arch Otolaryngol-Head Neck Surg. 2005;131(2):107&#x2013;112. doi: 10.1001/archotol.131.2.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.131.2.107</ArticleId><ArticleId IdType="pubmed">15723940</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Addison AB, Wong B, Ahmed T, Macchi A, Konstantinidis I, Huart C, et al. Clinical olfactory working group consensus statement on the treatment of post infectious olfactory dysfunction. J Allergy Clin Immunol. 2021;147(5):1704-1719. 10.1016/j.jaci.2020.12.641. Important article considering the frequncy of anosmia, hyposmia, and parosmia post COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33453291</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infect. J Med Virol. 2021 doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;32. 10.1016/s0140-6736(20)32656-8.&#xa0;A large 6-month cohort study reporting high prevalence of fatigue, anxiety, and depression long after the resolution of the initial symptoms of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Del Rio R, Marcus NJ, Inestrosa NC. Potential Role of autonomic dysfunction in Covid-19 morbidity and mortality. Front Physiol. 2020;11:561749. 10.3389/fphys.2020.561749.&#xa0;Article describing the potential role of autonomic dysfunction in COVID-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597395</ArticleId><ArticleId IdType="pubmed">33178034</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med (Lond). 2020. 10.7861/clinmed.2020-0896.&#xa0;As above, this article also includes physiology-based management strategies.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30(5):449&#x2013;51. doi: 10.1007/s10286-020-00727-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00727-9</ArticleId><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh R, Roy D, Sengupta S, Benito-Le&#xf3;n J. Autonomic dysfunction heralding acute motor axonal neuropathy in COVID-19. J Neurovirol. 2020;26(6):964&#x2013;6. doi: 10.1007/s13365-020-00908-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00908-2</ArticleId><ArticleId IdType="pmc">PMC7485423</ArticleId><ArticleId IdType="pubmed">32918164</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshak N, Abdelnabi M, Ball S, Elgwairi E, Creed K, Test V, et al. Dysautonomia: an overlooked neurological manifestation in a critically ill COVID-19 patient. Am J Med Sci. 2020;360(4):427&#x2013;9. doi: 10.1016/j.amjms.2020.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.07.022</ArticleId><ArticleId IdType="pmc">PMC7366085</ArticleId><ArticleId IdType="pubmed">32739039</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L, Jr, Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Transl Psychiatr. 2020;10(1):261. doi: 10.1038/s41398-020-00949-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-020-00949-5</ArticleId><ArticleId IdType="pmc">PMC7391235</ArticleId><ArticleId IdType="pubmed">32732883</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome &#x2013; evidence for an autoimmune disease. Autoimmun Rev. 2018;17(6):601&#x2013;9. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubasi AA, AbuAnzeh RB, Tawileh HBA, Aldebei RH, Alryalat SAS. A meta-analysis: the mortality and severity of COVID-19 among patients with mental disorders. Psychiatry Res. 2021;299:113856. doi: 10.1016/j.psychres.2021.113856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2021.113856</ArticleId><ArticleId IdType="pmc">PMC7927594</ArticleId><ArticleId IdType="pubmed">33740483</ArticleId></ArticleIdList></Reference><Reference><Citation>Egede J, Campbell JA, Walker RJ, Garacci E, Dawson AZ, Egede LE. Relationship between physical and mental health comorbidities and COVID-19 positivity, hospitalization, and mortality. J Affect Disord. 2021;283:94&#x2013;100. doi: 10.1016/j.jad.2021.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.01.048</ArticleId><ArticleId IdType="pmc">PMC7830241</ArticleId><ArticleId IdType="pubmed">33530015</ArticleId></ArticleIdList></Reference><Reference><Citation>Egede C, Dawson AZ, Walker RJ, Garacci E, Campbell JA, Egede LE. Relationship between mental health diagnoses and COVID-19 test positivity, hospitalization, and mortality in Southeast Wisconsin. Psychol Med. 2021 doi: 10.1017/S0033291721002312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291721002312</ArticleId><ArticleId IdType="pmc">PMC8185414</ArticleId><ArticleId IdType="pubmed">34034845</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Li F, Fortunati F, Krystal JH. Association of a prior psychiatric diagnosis with mortality among hospitalized patients with coronavirus disease 2019 (COVID-19) Infection. JAMA Netw Open. 2020;3(9):e2023282. doi: 10.1001/jamanetworkopen.2020.23282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.23282</ArticleId><ArticleId IdType="pmc">PMC7527869</ArticleId><ArticleId IdType="pubmed">32997123</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcella CA, Polcwiartek C, Mohr GH, Hodges G, S&#xf8;ndergaard K, Niels Bang C, et al. Severe mental illness is associated with increased mortality and severe course of COVID-19. Acta Psychiatr Scand. 2021 doi: 10.1111/acps.13309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acps.13309</ArticleId><ArticleId IdType="pmc">PMC8250986</ArticleId><ArticleId IdType="pubmed">33894064</ArticleId></ArticleIdList></Reference><Reference><Citation>Maripuu M, Bendix M, &#xd6;hlund L, Widerstr&#xf6;m M, Werneke U. Death associated with coronavirus (COVID-19) infection in individuals with severe mental disorders in Sweden during the early months of the outbreak-an exploratory cross-sectional analysis of a population-based register study. Front Psychiatr. 2020;11:609579. doi: 10.3389/fpsyt.2020.609579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.609579</ArticleId><ArticleId IdType="pmc">PMC7819873</ArticleId><ArticleId IdType="pubmed">33488430</ArticleId></ArticleIdList></Reference><Reference><Citation>Norden DM, Muccigrosso MM, Godbout JP. Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease. Neuropharmacology. 2015;96:29&#x2013;41. doi: 10.1016/j.neuropharm.2014.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2014.10.028</ArticleId><ArticleId IdType="pmc">PMC4430467</ArticleId><ArticleId IdType="pubmed">25445485</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Fonken LK, Frank MG, Gaudet AD, Maier SF. Stress and aging act through common mechanisms to elicit neuroinflammatory priming. Brain Behav Immun. 2018;73:133&#x2013;48. 10.1016/j.bbi.2018.07.012.&#xa0;Conceptual article that discusses the neuroinflammatory priming by stress and aging, affirming a psychological and a demographic factor that have similar biological effects to infectious, autoimmune, and traumatic factors.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6129421</ArticleId><ArticleId IdType="pubmed">30009999</ArticleId></ArticleIdList></Reference><Reference><Citation>Niraula A, Sheridan JF, Godbout JP. Microglia priming with aging and stress. Neuropsychopharmacology. 2017;42(1):318&#x2013;33. doi: 10.1038/npp.2016.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2016.185</ArticleId><ArticleId IdType="pmc">PMC5143497</ArticleId><ArticleId IdType="pubmed">27604565</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay TL, B&#xe9;chade C, D&#x2019;Andrea I, St-Pierre M-K, Henry MS, Roumier A, et al. Microglia gone rogue: impacts on psychiatric disorders across the lifespan. Front Mol Neurosci. 2018 doi: 10.3389/fnmol.2017.00421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00421</ArticleId><ArticleId IdType="pmc">PMC5758507</ArticleId><ArticleId IdType="pubmed">29354029</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley MJ, Brough D, Quintin J, Allan SM. Microglial priming as trained immunity in the brain. Neuroscience. 2019;405:47&#x2013;54. doi: 10.1016/j.neuroscience.2017.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.12.039</ArticleId><ArticleId IdType="pubmed">29292078</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol. 2005;5(3):243&#x2013;51. doi: 10.1038/nri1571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1571</ArticleId><ArticleId IdType="pubmed">15738954</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller GE, Chen E, Sze J, Marin T, Arevalo JMG, Doll R, et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatr. 2008;64(4):266&#x2013;72. doi: 10.1016/j.biopsych.2008.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2008.03.017</ArticleId><ArticleId IdType="pmc">PMC2581622</ArticleId><ArticleId IdType="pubmed">18440494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohleb ES, Powell ND, Godbout JP, Sheridan JF. Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. J Neurosci. 2013;33(34):13820&#x2013;33. doi: 10.1523/JNEUROSCI.1671-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1671-13.2013</ArticleId><ArticleId IdType="pmc">PMC3755721</ArticleId><ArticleId IdType="pubmed">23966702</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020;14(5):779&#x2013;88. doi: 10.1016/j.dsx.2020.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.05.035</ArticleId><ArticleId IdType="pmc">PMC7255207</ArticleId><ArticleId IdType="pubmed">32526627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanherwegen A-S, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am. 2017;46(4):1061&#x2013;94. doi: 10.1016/j.ecl.2017.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2017.07.010</ArticleId><ArticleId IdType="pubmed">29080635</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts DR, Chastain EML, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunol Rev. 2013;255(1):197&#x2013;209. doi: 10.1111/imr.12091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12091</ArticleId><ArticleId IdType="pmc">PMC3971377</ArticleId><ArticleId IdType="pubmed">23947356</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch DR, Rattelle A, Dong YN, Roslin K, Gleichman AJ, Panzer JA. Anti-NMDA receptor encephalitis: clinical features and basic mechanisms. Adv Pharmacol. 2018;82:235&#x2013;60. doi: 10.1016/bs.apha.2017.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.apha.2017.08.005</ArticleId><ArticleId IdType="pubmed">29413523</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalmau J, Armangu&#xe9; T, Planagum&#xe0; J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045&#x2013;57. doi: 10.1016/S1474-4422(19)30244-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30244-3</ArticleId><ArticleId IdType="pubmed">31326280</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams TJ, Benavides DR, Patrice KA, Dalmau JO, de &#xc1;vila AL, Le DT, et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol. 2016;73(8):928&#x2013;33. doi: 10.1001/jamaneurol.2016.1399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.1399</ArticleId><ArticleId IdType="pubmed">27271951</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;ftberger R, Lassmann H. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalomyelitis. Infections of the Central Nervous System. 2020. p. 251&#x2013;7.</Citation></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Lee FE-H, Sanz I. Broadly-targeted autoreactivity is common in severe SARS-CoV-2 Infection. medRxiv. 2020:2020.&#xa0;10.1101/2020.10.21.20216192.</Citation></Reference><Reference><Citation>Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154&#x2013;164. doi: 10.3947/ic.2020.52.2.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2020.52.2.154</ArticleId><ArticleId IdType="pmc">PMC7335648</ArticleId><ArticleId IdType="pubmed">32537961</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrientos RM, Frank MG, Hein AM, Higgins EA, Watkins LR, Rudy JW, et al. Time course of hippocampal IL-1 &#x3b2; and memory consolidation impairments in aging rats following peripheral infection. Brain Behav Immun. 2009;23(1):46&#x2013;54. doi: 10.1016/j.bbi.2008.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2008.07.002</ArticleId><ArticleId IdType="pmc">PMC2630971</ArticleId><ArticleId IdType="pubmed">18664380</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun. 2008;22(3):301&#x2013;11. doi: 10.1016/j.bbi.2007.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2007.08.014</ArticleId><ArticleId IdType="pmc">PMC2374919</ArticleId><ArticleId IdType="pubmed">17951027</ArticleId></ArticleIdList></Reference><Reference><Citation>Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kelley KW, et al. Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system. FASEB J. 2005;19(10):1329&#x2013;31. doi: 10.1096/fj.05-3776fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-3776fje</ArticleId><ArticleId IdType="pubmed">15919760</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging. 2008;29(11):1744&#x2013;53. doi: 10.1016/j.neurobiolaging.2007.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.04.012</ArticleId><ArticleId IdType="pmc">PMC2647751</ArticleId><ArticleId IdType="pubmed">17543422</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank MG, Barrientos RM, Watkins LR, Maier SF. Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo. J Neuroimmunol. 2010;226(1):181&#x2013;4. doi: 10.1016/j.jneuroim.2010.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.05.022</ArticleId><ArticleId IdType="pmc">PMC2937085</ArticleId><ArticleId IdType="pubmed">20537730</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: a systematic review and meta-analysis. J Med Virol. 2020;93(1):257-261. doi:10.1002/jmv.26237. Systematic review and metaanalysis of COVID-19 with importance for prognosis, for clinical approaches, for prevention, and for methodological considerations, i.e., adjustments for BMI and obesity status in those frequent instances when there is potential for confounding.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361606</ArticleId><ArticleId IdType="pubmed">32603481</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS ONE. 2015;10(3):e0121971. doi: 10.1371/journal.pone.0121971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0121971</ArticleId><ArticleId IdType="pmc">PMC4363366</ArticleId><ArticleId IdType="pubmed">25781614</ArticleId></ArticleIdList></Reference><Reference><Citation>Jais A, Br&#xfc;ning JC. Hypothalamic inflammation in obesity and metabolic disease. J Clin Invest. 2017;127(1):24&#x2013;32. doi: 10.1172/jci88878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci88878</ArticleId><ArticleId IdType="pmc">PMC5199695</ArticleId><ArticleId IdType="pubmed">28045396</ArticleId></ArticleIdList></Reference><Reference><Citation>Cope EC, LaMarca EA, Monari PK, Olson LB, Martinez S, Zych AD, et al. Microglia play an active role in obesity-associated cognitive decline. J Neurosci. 2018;38(41):8889&#x2013;904. doi: 10.1523/jneurosci.0789-18.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.0789-18.2018</ArticleId><ArticleId IdType="pmc">PMC6181311</ArticleId><ArticleId IdType="pubmed">30201764</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843&#x2013;851. doi: 10.1111/apt.15731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15731</ArticleId><ArticleId IdType="pmc">PMC7161803</ArticleId><ArticleId IdType="pubmed">32222988</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020 doi: 10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020 doi: 10.1053/j.gastro.2020.05..</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktas B, Aslim B. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol. 2020;44(3):265&#x2013;272. doi: 10.3906/biy-2005-102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/biy-2005-102</ArticleId><ArticleId IdType="pmc">PMC7314510</ArticleId><ArticleId IdType="pubmed">32595361</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey MT, Engler H, Sheridan JF. Stress induces the translocation of cutaneous and gastrointestinal microflora to secondary lymphoid organs of C57BL/6 mice. J Neuroimmunol. 2006;171(1&#x2013;2):29&#x2013;37. doi: 10.1016/j.jneuroim.2005.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2005.09.008</ArticleId><ArticleId IdType="pubmed">16253348</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37(1):137&#x2013;62. doi: 10.1038/npp.2011.205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2011.205</ArticleId><ArticleId IdType="pmc">PMC3238082</ArticleId><ArticleId IdType="pubmed">21918508</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun. 2011;25(3):397&#x2013;407. doi: 10.1016/j.bbi.2010.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.10.023</ArticleId><ArticleId IdType="pmc">PMC3039072</ArticleId><ArticleId IdType="pubmed">21040780</ArticleId></ArticleIdList></Reference><Reference><Citation>Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019;4(4):623&#x2013;32. doi: 10.1038/s41564-018-0337-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0337-x</ArticleId><ArticleId IdType="pubmed">30718848</ArticleId></ArticleIdList></Reference><Reference><Citation>Flux MC, Lowry CA. Finding intestinal fortitude: integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience. Neurobiol Dis. 2020;135:104578. doi: 10.1016/j.nbd.2019.104578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104578</ArticleId><ArticleId IdType="pmc">PMC6995775</ArticleId><ArticleId IdType="pubmed">31454550</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zheng P, Li Y, Wu J, Tan X, Zhou J, et al. Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. Sci Adv. 2020;6(49):eaba555. doi: 10.1126/sciadv.aba8555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aba8555</ArticleId><ArticleId IdType="pmc">PMC7710361</ArticleId><ArticleId IdType="pubmed">33268363</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008;29(1):117&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">18283240</ArticleId></ArticleIdList></Reference><Reference><Citation>Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010;170(4):1179&#x2013;1188. doi: 10.1016/j.neuroscience.2010.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.08.005</ArticleId><ArticleId IdType="pubmed">20696216</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclercq S, Forsythe P, Bienenstock J. Posttraumatic stress disorder: does the gut microbiome hold the key? Can J Psychiatry. 2016;61(4):204&#x2013;213. doi: 10.1177/0706743716635535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0706743716635535</ArticleId><ArticleId IdType="pmc">PMC4794957</ArticleId><ArticleId IdType="pubmed">27254412</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F, Du L, Ojcius DM, Pan C, Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan. China Microbes Infect. 2020;22(2):74&#x2013;9. doi: 10.1016/j.micinf.2020.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7102556</ArticleId><ArticleId IdType="pubmed">32017984</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11(1):874. doi: 10.3390/v11010059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010059</ArticleId><ArticleId IdType="pmc">PMC6357155</ArticleId><ArticleId IdType="pubmed">30646565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565&#x2013;74. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Harthi A, Hussein J, Bouchama A, Johani S, Hajeer AH, et al. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) Infection. 2015;43(4):495&#x2013;501. doi: 10.1007/s15010-015-0720-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-015-0720-y</ArticleId><ArticleId IdType="pmc">PMC4521086</ArticleId><ArticleId IdType="pubmed">25600929</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai LK, Hsieh ST, Chang YC. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan. 2005;14(3):113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16252612</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathi T, Kor AC, Venketasubramanian N, Lim CC, Pang BC, Yeo TT, et al. Large artery ischaemic stroke in severe acute respiratory syndrome (SARS) J Neurol. 2004;251(10):1227&#x2013;31. doi: 10.1007/s00415-004-0519-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-004-0519-8</ArticleId><ArticleId IdType="pmc">PMC7088071</ArticleId><ArticleId IdType="pubmed">15503102</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak IWC, Chu CM, Pan PC, Yiu MGC, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009;31(4):318&#x2013;26. doi: 10.1016/j.genhosppsych.2009.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2009.03.001</ArticleId><ArticleId IdType="pmc">PMC7112501</ArticleId><ArticleId IdType="pubmed">19555791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142&#x2013;7. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta -analysis. J Rehabil Med. 2020;52(5):jrm00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, Xie X, Hinton PR, Liu X, Ye X, Muruato AE, et al. Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature. 2021 doi: 10.1038/s41586-021-03673-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03673-2</ArticleId><ArticleId IdType="pmc">PMC8742224</ArticleId><ArticleId IdType="pubmed">34082438</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazal M, Souza LD, Fucolo BA, Wiener CD, Silva RA, Pinheiro RT, et al. The impact of cognitive behavioral therapy on IL-6 levels in unmedicated women experiencing the first episode of depression: a pilot study. Psychiatry Res. 2013;209(3):742&#x2013;5. doi: 10.1016/j.psychres.2013.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2013.03.002</ArticleId><ArticleId IdType="pubmed">23541242</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapiovaara L, Lehtoranta L, Poussa T, M&#xe4;kivuokko H, Korpela R, Pitk&#xe4;ranta A. Absence of adverse events in healthy individuals using probiotics&#x2013;analysis of six randomised studies by one study group. Beneficial Microbes. 2016;7(2):161&#x2013;169. doi: 10.3920/bm2015.0096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/bm2015.0096</ArticleId><ArticleId IdType="pubmed">26689224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanauchi O, Andoh A, AbuBakar S, Yamamoto N. Probiotics and paraprobiotics in viral infection: clinical application and effects on the innate and acquired immune systems. Curr Pharm Des. 2018;24(6):710&#x2013;7. doi: 10.2174/1381612824666180116163411.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612824666180116163411</ArticleId><ArticleId IdType="pmc">PMC6006794</ArticleId><ArticleId IdType="pubmed">29345577</ArticleId></ArticleIdList></Reference><Reference><Citation>Isolauri E, S&#xfc;tas Y, Kankaanp&#xe4;&#xe4; P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(2 Suppl):444s&#x2013;s450. doi: 10.1093/ajcn/73.2.444s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/73.2.444s</ArticleId><ArticleId IdType="pubmed">11157355</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner LA, Forster JE, Stearns-Yoder KA, Stamper CE, Hoisington AJ, Brostow DP, et al. Evaluation of an immunomodulatory probiotic intervention for veterans with co-occurring mild traumatic brain injury and posttraumatic stress disorder: a pilot study. Front Neurol. 2020;11(1015):841. doi: 10.3389/fneur.2020.01015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.01015</ArticleId><ArticleId IdType="pmc">PMC7641622</ArticleId><ArticleId IdType="pubmed">33192959</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720&#x2013;6. doi: 10.1016/j.biopsych.2013.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2013.05.001</ArticleId><ArticleId IdType="pubmed">23759244</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed H, Elshafeey A, Al-Ali D, Janjua E, Nauman A, Kawas H, et al. The interplay between the immune system, the renin-angiotensin-aldosterone system (RAAS), and RAAS inhibitors may modulate the outcome of COVID-19: a systematic review. J Clin Pharmacol. 2021 doi: 10.1002/jcph.1852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.1852</ArticleId><ArticleId IdType="pmc">PMC8014479</ArticleId><ArticleId IdType="pubmed">33635546</ArticleId></ArticleIdList></Reference><Reference><Citation>Chechneva OV, Deng W. Mitochondrial translocator protein (TSPO), astrocytes and neuroinflammation. Neural Regen Res. 2016;11(7):1056&#x2013;7. doi: 10.4103/1673-5374.187027.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.187027</ArticleId><ArticleId IdType="pmc">PMC4994436</ArticleId><ArticleId IdType="pubmed">27630677</ArticleId></ArticleIdList></Reference><Reference><Citation>Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatr. 2015;72(3):268&#x2013;275. doi: 10.1001/jamapsychiatry.2014.2427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2014.2427</ArticleId><ArticleId IdType="pmc">PMC4836849</ArticleId><ArticleId IdType="pubmed">25629589</ArticleId></ArticleIdList></Reference><Reference><Citation>Notter T, Coughlin JM, Sawa A, Meyer U. Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. Mol Psychiatr. 2018;23(1):36&#x2013;47. doi: 10.1038/mp.2017.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2017.232</ArticleId><ArticleId IdType="pubmed">29203847</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang TF, Chu H, Ou SM, Li SY, Chen YT, Shih CJ, et al. Effect of statin therapy on mortality in patients with infective endocarditis. Am J Cardiol. 2014;114(1):94&#x2013;99. doi: 10.1016/j.amjcard.2014.03.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2014.03.064</ArticleId><ArticleId IdType="pubmed">24819895</ArticleId></ArticleIdList></Reference><Reference><Citation>Caffrey AR, Timbrook TT, Noh E, Sakoulas G, Opal SM, Nizet V, et al. Evidence to support continuation of statin therapy in patients with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2017;61(3):84. doi: 10.1128/AAC.02228-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02228-16</ArticleId><ArticleId IdType="pmc">PMC5328562</ArticleId><ArticleId IdType="pubmed">28069650</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu SY, Hsieh MS, Lin TC, Liao SH, Hsieh VC, Chiang JH, et al. Statins improve the long-term prognosis in patients who have survived sepsis: a nationwide cohort study in Taiwan (STROBE complaint) Medicine (Baltimore) 2019;98(17):e15253. doi: 10.1097/MD.0000000000015253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000015253</ArticleId><ArticleId IdType="pmc">PMC6831426</ArticleId><ArticleId IdType="pubmed">31027074</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung TH, Tsai CC, Lee HF. Statin use in cirrhotic patients with infectious diseases: a population-based study. PLoS ONE. 2019;14(4):e0215839. doi: 10.1371/journal.pone.0215839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0215839</ArticleId><ArticleId IdType="pmc">PMC6481830</ArticleId><ArticleId IdType="pubmed">31017946</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng CY, Kung CT, Chen FC, Cheng HH, Tsai TC, Hsiao SY, et al. Impact of prior statin use on mortality in patients with type 2 diabetes mellitus and bloodstream infection. J Int Med Res. 2019;47(8):3636&#x2013;3647. doi: 10.1177/0300060519856137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060519856137</ArticleId><ArticleId IdType="pmc">PMC6726825</ArticleId><ArticleId IdType="pubmed">31234680</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapey E, Patel JM, Greenwood H, Walton GM, Grudzinska F, Parekh D, et al. Simvastatin improves neutrophil function and clinical outcomes in pneumonia. a pilot randomized controlled clinical trial. Am J Respir Crit Care Med. 2019;200(10):1282&#x2013;1293. doi: 10.1164/rccm.201812-2328OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201812-2328OC</ArticleId><ArticleId IdType="pmc">PMC6857486</ArticleId><ArticleId IdType="pubmed">31206313</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani T, Liappis AP, Baddour LM, Karasik PE. Statin use and the risk of cardiovascular implantable electronic device infection: a cohort study in a veteran population. Pacing Clin Electrophysiol. 2018;41(3):284&#x2013;289. doi: 10.1111/pace.13285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.13285</ArticleId><ArticleId IdType="pubmed">29341172</ArticleId></ArticleIdList></Reference><Reference><Citation>Argamany JR, Lee GC, Duhon BD, Zeidan AR, Young EH, Reveles KR. A possible association between statin use and improved Clostridioides difficile infection mortality in veterans. PLoS ONE. 2019;14(5):e0217423. doi: 10.1371/journal.pone.0217423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0217423</ArticleId><ArticleId IdType="pmc">PMC6538245</ArticleId><ArticleId IdType="pubmed">31136602</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Mahmood A, Lu D, Wu H, Xiong Y, Qu C, et al. Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury. Neurosurgery. 2009;65(1):179&#x2013;186. doi: 10.1227/01.NEU.0000346272.76537.DC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/01.NEU.0000346272.76537.DC</ArticleId><ArticleId IdType="pmc">PMC2749520</ArticleId><ArticleId IdType="pubmed">19574840</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollmer T, Key L, Durkalski V, Tyor W, Corboy J, Markovic-Plese S, et al. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet. 2004;363(9421):1607&#x2013;08. doi: 10.1016/S0140-6736(04)16205-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)16205-3</ArticleId><ArticleId IdType="pubmed">15145635</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020;12(7):8413. doi: 10.3390/nu12072097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072097</ArticleId><ArticleId IdType="pmc">PMC7400911</ArticleId><ArticleId IdType="pubmed">32679784</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010;39(2):365&#x2013;79. doi: 10.1016/j.ecl.2010.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2010.02.010</ArticleId><ArticleId IdType="pmc">PMC2879394</ArticleId><ArticleId IdType="pubmed">20511058</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open. 2020;3(9):e2019722. doi: 10.1001/jamanetworkopen.2020.19722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.19722</ArticleId><ArticleId IdType="pmc">PMC7489852</ArticleId><ArticleId IdType="pubmed">32880651</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Kaur R, Singh RK. Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak. Aging Clin Exp Res. 2020;32(8):1609&#x2013;1612. doi: 10.1007/s40520-020-01619-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01619-8</ArticleId><ArticleId IdType="pmc">PMC7426200</ArticleId><ArticleId IdType="pubmed">32797388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye K, Tang F, Liao X, Shaw BA, Deng M, Huang G, et al. Does serum vitamin D level affect COVID-19 infection and its severity?-a case-control study. J Am Coll Nutr. 2020 doi: 10.1080/07315724.2020.1826005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2020.1826005</ArticleId><ArticleId IdType="pubmed">33048028</ArticleId></ArticleIdList></Reference><Reference><Citation>Baktash V, Hosack T, Patel N, Shah S, Kandiah P, Van Den Abbeele K, et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. 2020 doi: 10.1136/postgradmedj-2020-138712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138712</ArticleId><ArticleId IdType="pmc">PMC7456620</ArticleId><ArticleId IdType="pubmed">32855214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez JL, Nan D, Fernandez-Ayala M, Garc&#xed;a-Unzueta M, Hern&#xe1;ndez-Hern&#xe1;ndez MA, L&#xf3;pez-Hoyos M, et al. Vitamin D status in hospitalized patients with SARS-CoV-2 infection. J Clin Endocrinol Metab. 2020 doi: 10.1210/clinem/dgaa733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa733</ArticleId><ArticleId IdType="pmc">PMC7797757</ArticleId><ArticleId IdType="pubmed">33159440</ArticleId></ArticleIdList></Reference><Reference><Citation>Benskin L. A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency. Front Publ Health. 2020;8(513):45. doi: 10.3389/fpubh.2020.00513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00513</ArticleId><ArticleId IdType="pmc">PMC7513835</ArticleId><ArticleId IdType="pubmed">33014983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugach IZ, Pugach S. Strong correlation between prevalence of severe vitamin D deficiency and population mortality rate from COVID-19 in Europe. medRxiv. 2020:2020.06.24.20138644. 10.1101/2020.06.24.20138644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7957444</ArticleId><ArticleId IdType="pubmed">33721102</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes JM, Subramanian S, Laird E, Kenny RA. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther. 2020;51(12):1434&#x2013;37. doi: 10.1111/apt.15777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15777</ArticleId><ArticleId IdType="pmc">PMC7264531</ArticleId><ArticleId IdType="pubmed">32311755</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaya F, Espejo Paeres C, Valls A, Fern&#xe1;ndez-Ortiz A, Gonz&#xe1;lez Del Castillo J, Mart&#xed;n-S&#xe1;nchez FJ, et al. Interaction between age and vitamin D deficiency in severe COVID-19 infection. Nutr Hosp. 2020;37(5):1039&#x2013;42. doi: 10.20960/nh.03193.</Citation><ArticleIdList><ArticleId IdType="doi">10.20960/nh.03193</ArticleId><ArticleId IdType="pubmed">32960622</ArticleId></ArticleIdList></Reference><Reference><Citation>Postolache TT, Benros ME, Brenner LA. Targetable biological mechanisms implicated in emergent psychiatric conditions associated with SARS-CoV-2 infection. JAMA Psychiat. 2020 doi: 10.1001/jamapsychiatry.2020.2795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.2795</ArticleId><ArticleId IdType="pubmed">32735332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021 doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><ReferenceList><Title>Papers of particular interest, published recently, have been highlighted as: &#x2022; Of importance &#x2022;&#x2022; Of major importance</Title><Reference><Citation>National Center for Health Statistics (NCHS), Census Bureau. Mental Health - Household Pulse Survey - COVID-19. 2020. https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm. Accessed November 27,&#xa0;2020.</Citation></Reference><Reference><Citation>Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatr. 2021;20(1):124&#x2013;30. doi: 10.1002/wps.20806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20806</ArticleId><ArticleId IdType="pmc">PMC7675495</ArticleId><ArticleId IdType="pubmed">33026219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemani K, Li C, Olfson M, Blessing EM, Razavian N, Chen J, et al. Association of psychiatric disorders with mortality among patients with COVID-19. JAMA Psychiatr. 2021;78(4):380&#x2013;6. doi: 10.1001/jamapsychiatry.2020.4442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.4442</ArticleId><ArticleId IdType="pmc">PMC7841576</ArticleId><ArticleId IdType="pubmed">33502436</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik YA. Properties of coronavirus and SARS-CoV-2. Malays J Pathol. 2020;42(1):3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32342926</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Chen W, Zhou Y-S, Lian J-Q, Zhang Z, Du P, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. 2020:2020.03.14.988345.&#xa0;10.1101/2020.03.14.988345.</Citation></Reference><Reference><Citation>&#x2022;&#x2022; Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260&#x2013;3. 10.1126/science.abb2507.&#xa0;Describes particularities of SARS-CoV 2 leading to its stonger affinity for ACE2 facilitating cell entry.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>